Commentary on Schmitz : Advancing medication development for addiction—behavioral and neuroimaging outcomes as indirect biomarkers of target engagementet al: Advancing medication development for addiction—behavioral and neuroimaging outcomes as indirect biomarkers of target engagement. (2017): Advancing medication development for addiction—behavioral and neuroimaging outcomes as indirect biomarkers of target engagement

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles